A COMPARISON OF THE INHIBITORY EFFECTS OF ROXATIDINE ACETATE HYDROCHLORIDE AND CIMETIDINE ON CYTOCHROME P-450-MEDIATED DRUG-METABOLISM IN MOUSE HEPATIC MICROSOMES AND IN MAN IN VIVO
スポンサーリンク
概要
- 論文の詳細を見る
The inhibitory effects of roxatidine acetate hydrochloride (ROX), a new H_2-receptor antagonist, on the oxidative drug-metabolizing enzyme system in mouse hepatic microsomes and in man in vivo were compared with those of cimetidine (CIM). CIM markedly inhibited testosterone 6β-, 7α- and 16α-hydroxylase, aminopyrine N-demethylase and aniline hydroxylase activities in mouse hepatic microsomes with inhibition constants (K_i) of 0.2-3.49 mM. ROX exhibited much weaker inhibitory effects on each enzyme activity with 12 to 100-fold higher values of K_i than those of CIM. CIM gave type II difference spectra with dissociation constants (K_s) of 10.4 and 111 μM while ROX gave reverse type I difference spectra with K_s of 55.6 μM. The ratio of 6β-hydroxycortisol (6β-OHF) to 17-hydroxy corticosteroids (17-OHCS) in urine, used as an indicator of oxidative drugmetabolizing capacity in man, was decreased by 25-35% of the original level on 1-3 d after oral treatment with 800 mg/d of CIM. The ratio was not significantly changed during oral treatment with 150 mg/d of ROX. These results indicate that ROX exhibits a lower affinity for cytochrome P-450 and a lower inhibitory potency on the drug-metabolizing enzymes in hepatic microsomes than does CIM.
- 公益社団法人日本薬学会の論文
著者
-
Ono Takeshi
Hospital Pharmacy Shiga University Of Medical Science
-
Shimakawa H
Shiga Univ. Medical Science
-
Konishi H
National Inst. Agrobiological Sci. Tsukuba Jpn
-
Morita Kunihiko
Hospital Pharmacy Shiga University Of Medical Science
-
SHIMAKAWA Harumi
Hospital Pharmacy, Shiga University of Medical Science
-
KONISHI HIROKI
Hospital Pharmacy, Shiga University of Medical Science
-
Shimakawa Harumi
Hospital Pharmacy Shiga University Of Medical Science
関連論文
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS A POORLY ABBSORBABLE DRUG. III.^ HISTOLOGICAL STUDY AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RATS
- EFFECT OF ADMINISTRATION ROUTE ON THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. II. STUDY ON THE ABSORPTION PROMOTING EFFECT OF AZONE
- PROMOTION OF THE SELECTIVE LYMPHATIC DELIVERY OF CYCLOSPORIN A BY LIPID-SURFACTANT MIXED MICELLES
- ENHANCING EFFECT OF ABSORPTION PROMOTERS ON PERCUTANEOUS ABSORPTION OF A MODEL DYE (6-CARBOXYFLUORESCEIN) AS POORLY ABSORBABLE DRUGS. I. COMPARISON OF PLASMA LEVELS AFTER ADDITION OF VARIOUS ABSORPTION PROMOTERS IN RAT
- Inhibition of Testosterone Biosynthesis in Testicular Microsomes by Various Imidazole Drugs. Comparative Study with Ketoconazole
- A Model to Account for the Blood-to-Plasma Distribution of Cyclosporin A in Human Blood
- Effects of Antimycotics on Hepatic Steroid Metabolism
- Effects of Ozagrel (OKY-046), a Thromboxane Synthase Inhibitor, on Oxidative Drug-Metabolizing Enzymes in Mouse Hepatic Microsomes
- Effects of Diltiazem on Rheological Properties of Human Blood
- Inhibitory Effects of Ketoconazole and Miconazole on Cytochrome P-450-Mediated Oxidative Metabolism of Testosterone and Xenobiotics in Mouse Hepatic Microsomes-Comparative Study with Cimetidine
- A COMPARISON OF THE INHIBITORY EFFECTS OF ROXATIDINE ACETATE HYDROCHLORIDE AND CIMETIDINE ON CYTOCHROME P-450-MEDIATED DRUG-METABOLISM IN MOUSE HEPATIC MICROSOMES AND IN MAN IN VIVO
- Selective Inhibition of Hepatic Microsomal Drug-Metabolism by Mexiletine Hydrochloride
- Retrospective Pharmacokinetic Data Analysis of Cyclosporin A Using Routine Monitoring Data in Renal Transplant Patients : Consideration on Its Pharmacokinetic Profiles and Physiological Factors during Renal Dysfunction
- Evaluation of fluorescence polarization immunoassay for determination of cyclosporin in whole blood and its clinical relevance.